Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-28

Clinical Trial Update: Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial [Phase 3]

View source ↗

Summary

Phase 3 trial results for indomethacin prevention of germinal matrix/intraventricular hemorrhage in preterm (very low birth weight) infants have been completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Yale University | Conditions: Intraventricular Hemorrhage (IVH), Bleeding in the Brain | Phase 3 | Status: COMPLETED | Results posted: 2013-03-28